The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Feb. 11, 2020
Filed:
Dec. 17, 2014
Applicant:
Aimm Therapeutics B.v., Amsterdam Zuidoost, NL;
Inventors:
Hergen Spits, Amsterdam Zuidoost, NL;
Tim Beaumont, Amsterdam Zuidoost, NL;
Marijn Aletta Gillissen, Amsterdam Zuidoost, NL;
Adrianus Quirinus Bakker, Amsterdam Zuidoost, NL;
Mette Deborah Hazenberg, Amsterdam Zuidoost, NL;
Martijn Kedde, Amsterdam Zuidoost, NL;
Assignee:
AIMM THERAPEUTICS B.V., Amsterdam Zuidoost, NL;
Primary Examiner:
Int. Cl.
CPC ...
C07K 16/30 (2006.01); C07K 16/06 (2006.01); A61K 47/68 (2017.01); C07K 16/40 (2006.01); C12P 21/00 (2006.01); G01N 33/574 (2006.01);
U.S. Cl.
CPC ...
C07K 16/3061 (2013.01); A61K 47/6851 (2017.08); C07K 16/06 (2013.01); C07K 16/40 (2013.01); C12P 21/005 (2013.01); G01N 33/57492 (2013.01); C07K 2317/21 (2013.01); C07K 2317/33 (2013.01); C07K 2317/565 (2013.01); C07K 2317/73 (2013.01); C07K 2317/732 (2013.01); C07K 2317/734 (2013.01); G01N 2333/705 (2013.01);
Abstract
The invention provides human AML-specific binding compounds that are able to bind a cell surface component of AML cells. Therapeutic uses of binding compounds against AML are also provided.